In response to the growing need for reporting standards for evaluating artificial intelligence (AI) chatbot health advice studies for clinical purposes, researchers created the Chatbot Assessment Reporting Tool (CHART) so stakeholders can interpret results with confidence.

Manipulating the endocannabinoid signaling system in prenatal mice leads to long-lasting neural and genetic changes that may lead to social deficits.

Pea-sized brains grown in a lab have for the first time revealed the unique way neurons might misfire due to schizophrenia and bipolar disorder, psychiatric ailments that affect millions of people worldwide but are difficult to diagnose because of the lack of understanding of their molecular basis. The research only involved 12 patients, but the findings will likely have real-world, clinical application as they could be the beginning of an important testbed for psychiatric drug therapies.  

Researchers at Dana-Farber Cancer Institute have developed a groundbreaking diagnostic tool that could transform the way acute leukemia is identified and treated. The tool, called MARLIN (Methylation- and AI-guided Rapid Leukemia Subtype Inference), uses DNA methylation patterns and machine learning to classify acute leukemia with speed and accuracy. This tool has the potential to significantly improve patient care by allowing faster and more precise treatment decisions.